|
LUZP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.490800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.086400E-01 |
| Normal-vs-Stage2 |
8.945600E-01 |
| Normal-vs-Stage3 |
1.512050E-01 |
| Normal-vs-Stage4 |
1.655800E-01 |
| Stage1-vs-Stage2 |
7.814800E-01 |
| Stage1-vs-Stage3 |
2.821200E-01 |
| Stage1-vs-Stage4 |
2.811800E-01 |
| Stage2-vs-Stage3 |
3.520800E-01 |
| Stage2-vs-Stage4 |
3.501600E-01 |
| Stage3-vs-Stage4 |
9.911800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.598000E-01 |
| Normal-vs-AfricanAmerican |
5.5884000000006E-05 |
| Normal-vs-Asian |
4.816000E-01 |
| Caucasian-vs-AfricanAmerican |
1.98871999999017E-05 |
| Caucasian-vs-Asian |
2.599200E-01 |
| AfricanAmerican-vs-Asian |
1.002000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.020600E-01 |
| Normal-vs-Female |
8.582300E-02 |
| Male-vs-Female |
1.778650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.511800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.893800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.119000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.595800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.556600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.109400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.658300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.221600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.474030E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.103600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.445000E-01 |
| Normal-vs-Grade 2 |
9.646600E-01 |
| Normal-vs-Grade 3 |
5.584200E-02 |
| Normal-vs-Grade 4 |
2.343400E-01 |
| Grade 1-vs-Grade 2 |
8.231200E-01 |
| Grade 1-vs-Grade 3 |
5.237600E-01 |
| Grade 1-vs-Grade 4 |
7.095200E-01 |
| Grade 2-vs-Grade 3 |
2.045600E-02 |
| Grade 2-vs-Grade 4 |
2.069200E-01 |
| Grade 3-vs-Grade 4 |
8.054800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.466800E-01 |
| Normal-vs-ccB subtype |
9.371800E-01 |
| ccA subtype-vs-ccB subtype |
7.757200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.520000E-01 |
| Normal-vs-N1 |
5.123200E-01 |
| N0-vs-N1 |
4.010000E-01 |
|
|
